COPD treatment with patient using correct medicine dosage is what will set AstraZeneca's drug apart from other...if they want exclusivity to this screening tool.
https://www.biospace.com/article/fda-approves-astrazeneca-s-copd-treatment-breztri-aerosphere/
RAP media thread., page-1580
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #